MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin

Background/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of triste...

Full description

Bibliographic Details
Main Authors: Xian-Jun Sun, Bing-Yan Liu, Shuo Yan, Ting-Hui Jiang, Hui-Qin Cheng, Hao-Sheng Jiang, Yan Cao, Ai-Wu Mao
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-09-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/430389
_version_ 1818132214376824832
author Xian-Jun Sun
Bing-Yan Liu
Shuo Yan
Ting-Hui Jiang
Hui-Qin Cheng
Hao-Sheng Jiang
Yan Cao
Ai-Wu Mao
author_facet Xian-Jun Sun
Bing-Yan Liu
Shuo Yan
Ting-Hui Jiang
Hui-Qin Cheng
Hao-Sheng Jiang
Yan Cao
Ai-Wu Mao
author_sort Xian-Jun Sun
collection DOAJ
description Background/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of tristetraprolin (TTP). Methods: We monitored miR-29a and TTP expression in pancreatic cancer by qRT-PCR and western blotting. The effect of miR-29a on pancreatic cancer was determined through MTT assay and migration assay. The results were validated in the tumorigenesis model. Results: We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis. Ectopic expression of miR-29a increased the expression of pro-inflammatory factors and epithelial-mesenchymal transition (EMT) markers, through down regulating TTP. TTP was down regulated in tumor tissues, and its ectopic expression decreased cell viability and migration in vitro, inhibited tumor growth and the EMT phenotype in vivo, and reversed the effect of miR-29a on tumor cell proliferation and invasion in vitro and in vivo. Conclusion: Our results suggest that miR-29a acts as an oncogene by down regulating TTP and provide the basis for further studies exploring the potential of miR-29a and TTP as biomarkers and targets for the treatment of pancreatic cancer.
first_indexed 2024-12-11T08:33:16Z
format Article
id doaj.art-0b302604dc0e4a3286aa11b47d70e2c9
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-11T08:33:16Z
publishDate 2015-09-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-0b302604dc0e4a3286aa11b47d70e2c92022-12-22T01:14:24ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782015-09-0137270771810.1159/000430389430389MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting TristetraprolinXian-Jun SunBing-Yan LiuShuo YanTing-Hui JiangHui-Qin ChengHao-Sheng JiangYan CaoAi-Wu MaoBackground/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of tristetraprolin (TTP). Methods: We monitored miR-29a and TTP expression in pancreatic cancer by qRT-PCR and western blotting. The effect of miR-29a on pancreatic cancer was determined through MTT assay and migration assay. The results were validated in the tumorigenesis model. Results: We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis. Ectopic expression of miR-29a increased the expression of pro-inflammatory factors and epithelial-mesenchymal transition (EMT) markers, through down regulating TTP. TTP was down regulated in tumor tissues, and its ectopic expression decreased cell viability and migration in vitro, inhibited tumor growth and the EMT phenotype in vivo, and reversed the effect of miR-29a on tumor cell proliferation and invasion in vitro and in vivo. Conclusion: Our results suggest that miR-29a acts as an oncogene by down regulating TTP and provide the basis for further studies exploring the potential of miR-29a and TTP as biomarkers and targets for the treatment of pancreatic cancer.http://www.karger.com/Article/FullText/430389Pancreatic cancerMicroRNA-29aTristetraprolin
spellingShingle Xian-Jun Sun
Bing-Yan Liu
Shuo Yan
Ting-Hui Jiang
Hui-Qin Cheng
Hao-Sheng Jiang
Yan Cao
Ai-Wu Mao
MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
Cellular Physiology and Biochemistry
Pancreatic cancer
MicroRNA-29a
Tristetraprolin
title MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
title_full MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
title_fullStr MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
title_full_unstemmed MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
title_short MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
title_sort microrna 29a promotes pancreatic cancer growth by inhibiting tristetraprolin
topic Pancreatic cancer
MicroRNA-29a
Tristetraprolin
url http://www.karger.com/Article/FullText/430389
work_keys_str_mv AT xianjunsun microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT bingyanliu microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT shuoyan microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT tinghuijiang microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT huiqincheng microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT haoshengjiang microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT yancao microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin
AT aiwumao microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin